Skip to content
2000
Volume 17, Issue 1
  • ISSN: 1570-1786
  • E-ISSN: 1875-6255

Abstract

Cancer is a second leading cause of death after heart attack, in developing as well as undeveloped countries. It is caused by unregulated growth and metastasis of the abnormal cancer cells. Cancer can be cured by radiation, immunotherapy and chemotherapy, among them; chemotherapy is a good treatment for cancer, in which chemotherapeutic drug is used. The anticancer activity of newly synthesized compounds (13a-j) was carried out on four different types of human cancer cell lines like MCF-7 (breast), A549 (lung), Colo-205 (colon) and A2780 (ovarian) by the MTT method, and compared to etoposide used as a positive control. Among them, compound 13g with electron-withdrawing (3,5-dinitro) group, exhibited more promising activity in all cell lines (MCF-7 = 0.10±0.076 μM, A549 = 0.17±0.039 μM, Colo-205= 0.13±0.022 μM and A2780 = 0.87±0.027μM). This compound may act as lead drug in cancer chemotherapy. In future, this compound can be examined for clinical studies.

Loading

Article metrics loading...

/content/journals/loc/10.2174/1570178616666190528095548
2020-01-01
2025-09-09
Loading full text...

Full text loading...

/content/journals/loc/10.2174/1570178616666190528095548
Loading

  • Article Type:
    Research Article
Keyword(s): anticancer activity; cancer; pralatrexate; Pteridone; thiamethoxam; triamterene
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test